Kliniske forsøg Neupros effekt ved behandlingen af tegn og symptomer ved idiopatisk Parkinsons sygdom er vurderet i et multinationalt lægemiddeludviklingsprogram bestående af fire pivotale, parallelle, randomiserede, dobbeltblinde, placebokontrollerede forsøg.
The effectiveness of Neupro in the treatment of the signs and symptoms of idiopathic Parkinson's disease was evaluated in a multinational drug development program consisting of four pivotal, parallel, randomized, double-blind placebo controlled studies.